| January 22, 2004 | ||
|---|---|---|
| Time | Topic/Links to Slides | Presenter |
| 8:45 am–9:00 am | Welcome | Thomas Insel, M.D. & Wayne Fenton, M.D. |
| 9:00 am–10:15 am | Presentations by NIMH Staff | Ellen Stover, Ph.D., Chair |
| 9:00 am–9:20 am | Linda Brady, Ph.D. |
|
| 9:20 am–9:30 am | DMDBA (Schizophrenia and Cognition Initiatives) | Wayne Fenton, M.D |
| 9:30 am–9:40 am | DSIR (Phase III Clinical Trials) | Grayson Norquist, M.D., M.S.P.H. |
| 9:40 am–10:00 am | DIRP | Dennis Charney, M.D. |
| 10:00 am–10:15 am | Questions/Discussion | |
| 10:15 am–10:45 am | Overview of Drug Discovery and Development | Steven Paul, M.D. |
| 10:45 | Break | |
| 11:00 am | Question 1: Working lunch |
Edward Scolnick, M.D., Discussion leader |
| 1:00 pm | Question
2: Can the NIMH large clinical trial networks evolve into a resource for public-private partnerships? |
Thomas Insel, M.D., Discussion Leader |
| 2:00 pm | Question 3:
What are major barriers to better industry-intramural and industry-extramural collaboration in drug development and how might they be remedied? |
Herbert Pardes, M.D., Discussion Leader |
| 3:00 pm | Summary of Recommendations | |
| 3:00 pm–3:10 pm | Question 1 | Edward Scolnick, M.D. |
| 3:10 pm–3:20 pm | Question 2 | Thomas Insel, M.D. |
| 3:20 pm–3:30 pm | Question 3 | Herbert Pardes, M.D. |
| 3:30 pm | Concluding Remarks | Thomas Insel, M.D. |
Contact matricsassessment@gmail.com for questions or comments about the MATRICS program and see our website - www.matricsinc.org - for details regarding the MATRICS Consensus Cognitive Battery (MCCB).
Contact support@matrics.ucla.edu for questions or comments about with this web site.
TURNS Home Page | UCLA Home Page | Terms of Use | Disability Resources at UCLA
| Revised: Sunday, 07-Mar-2004 21:21:38 PST |